The clearance was granted after two phase III studies that showed significant visual acuity improvement with EYLEA.
EYLEA was first approved to treat wet age-related Macular Degeneration.
More Articles on Ophthalmology:
Ophthalmologist Dr. George Primbs Recognized for Community Service
Glaucoma, Cataract Specialist Dr. Charles Weber Joins The Eye Institute of Utah
Eye Care Product Maker Akorn to Acquire Hi-Tech Pharmacal for $640M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.